FDA Orders Review of Painkiller Data, Issues Cox-2 Advisory
130636
The furor over the safety of arthritis painkilling medications shows no sign of abating. Vioxx is gone from the market, following data linking it to increased cardiovascular risk.
137354
The Food and Drug Administration announced Friday its intentions to conduct a major evaluation of its approach in dealing with safety concerns involving drugs, primarily those that are already marketed.
415778
NEW YORK, December 24  - The Food &amp; Drug Administration (FDA) announced yesterday that it planned to examine the various studies that link the usage of several painkillers with heightened cardiovascular risks, while recommending that
127685
FRIDAY, Dec. 17 (HealthDayNews) -- The U.S. government announced Friday it has  halted the use of Celebrex in a cancer trial because of heart risks, and it is reviewing the safety of all its clinical trials using similar painkillers.
81209
HUNDREDS of thousands of patients taking commonly prescribed painkillers should have their treatment reviewed by a doctor after growing concerns about possible health risks, a government watchdog said yesterday.
375225
U.S. health regulators warned on Monday of heart risks connected to over-the-counter painkiller naproxen, creating additional confusion over the safety of similar drugs after recent warnings for two other painkillers.
597708
Drug giant Merck says the Food and Drug Administration wants more information, but is prepared to approve the company&#39;s successor drug to recalled pain reliever Vioxx.
513761
The U.S. Food and Drug Administration on Friday asked an outside group to review the way it monitors safety risks associated with medicines already on the market, such as Merck & Co. Inc.'s withdrawn painkiller Vioxx.
131481
Nov. 5, 2004 -- FDA officials announced Friday that they will launch a review of the agency&#39;s drug monitoring policies in the wake of recent high-profile safety concerns about widely used drugs, including antidepressants and Vioxx.
238122
The Food and Drug Administration yesterday called for an evaluation of all prevention studies involving two controversial painkillers - Celebrex and Bextra - to ensure adequate protection for participants who use the pills.
373977
Two studies released yesterday have turned up new evidence that all of the popular arthritis painkillers known as cox-2 inhibitors may put users at greater risk of heart attacks and strokes.
79247
Merck &amp; Co., which withdrew the Vioxx painkiller last month because of a heart risk, said yesterday that US regulators have asked for more safety data before they will approve the medicine&#39;s successor, Arcoxia.
115447
The FDA (USA) says it did not try to suppress the findings of a safety official regarding the Vioxx painkiller. Vioxx was taken off the market last week because the drug increases a patient&#39;s risk of having a heart attack.
75561
Agency says painkillers, such as Alleve and Naprosyn, can cause an increased risk of heart problems. WASHINGTON  - The US Food and Drug Administration on Monday issued a warning to patients taking
326837
Last weekâs dramatic withdrawal of the COX-2 inhibitor rofecoxib (Vioxx) is discussed in this weekâs lead editorial in THE LANCET, which comments that more vigilant drug licensing is vital to prevent the endangering of patientsâ health.
286900
The US Food and Drug Administration says it plans to convene a panel of experts in February to discuss the safety of painkillers in the same class as the now-withdrawn drug Vioxx, but one member of the panel was asked not to come.
55610
The Food and Drug Administration recommended Thursday that doctors limit prescriptions for the popular pain pills Celebrex and Bextra because recent